Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel, Carboplatin, and Herceptin vs Vinorelbine and Herceptin in HER-2+ Metastatic Breast Cancer
NCT00453635Phase 2Terminated
- Sponsor
- Hellenic Oncology Research Group
- Start
- Dec 2003
- Primary completion
- Nov 2008
- Modality
- Antibody Conjugates, Monoclonal Antibodies, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, carboplatin, trastuzumab, vinorelbine in breast cancer, sponsored by Hellenic Oncology Research Group. Started Dec 2003; status: terminated.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00453635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453635.